未登录

J

Joshua C. Black

Denver Health Medical Center

H指数:13

被引数:544

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Motivations, perceived risk, and tampering of XTAMPZA ER and abuse-deterrent opioid drugs

动机、感知风险以及XTAMPZA ER和滥用抑制剂阿片类药物的篡改

IF2.6

2025-10-080

PRE

The prevalence of pharmacogenetic testing in the United States

美国药物基因组学检测的流行率

PHARMACOGENETICS AND GENOMICS

IF1.7

2025-10-010

PRE

Psychedelic Trips: Travel Within the United States to Use Psychedelic Drugs After Legalization

迷幻之旅：在合法化后前往美国境内使用迷幻药物

Annals of Emergency Medicine

IF5

2025-06-300

PRE

Trends in Nonfatal Fentanyl Exposures Involving Stimulants in the United States, 2015–2023

2015—2023年美国涉及兴奋剂的阿片类药物芬太尼非致命暴露趋势

American Journal of Preventive Medicine

IF4.5

2025-06-090

PRE

Nonfatal pediatric fentanyl exposures reported to US poison centers, 2015-2023

2015-2023年美国毒物中心报告的非致命儿科芬太尼暴露情况

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

IF2.6

2025-03-072

PRE

Trends in poisonings involving ketamine in the United States, 2019-2023

2019-2023年美国涉及氯胺酮的中毒趋势

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-03-010

PRE

People entering opioid substance use treatment have low rates of naloxone knowledge and possession

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-03-010

PRE

Comparison of heroin and fentanyl use in US nationally representative surveys

clinical psychology science and practice

IF3.2

2025-02-110

OAAI

Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022

ANNALS OF EMERGENCY MEDICINE

IF5

2024-12-011

PRE

Identifying and quantifying exposures involving counterfeit opioid analgesic products

CLINICAL TOXICOLOGY

IF3.3

2024-10-101

PRE

Risk Factors for Misuse Versus Abuse of Opioids and Sedatives

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Black Market Drug Purchases as Reported to RealTime Monitoring Website, StreetRx

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Commentary on Darke et al.: Expanded psychedelic access requires new safety monitoring systems

IF5.3

2024-06-171

OA

Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population

JOURNAL OF ADDICTION MEDICINE

IF3.2

2024-06-030

PRE

The Rise of Psychedelic Drug Use Associated With Legalization/ Decriminalization: An Assessment With the Nonmedical Use of Prescription Drugs Survey

ANNALS OF EMERGENCY MEDICINE

IF5

2024-03-014

PRE

Initiation Patterns and Transitions Among Adults Using Stimulant Drugs: Latent Transition Analysis

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2023-10-050

OA

Comparing Substance Use Consequences between Serotonergic Psychedelics, MDMA, and other Drugs of Abuse Among United States Adults with History of Psychiatric Illness

INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION

IF2.5

2023-09-261

OA

Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis

成人非医疗使用处方兴奋剂和阿片类药物的不同行为: 潜在类别分析

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2023-09-201

OA

Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic

PSYCHIATRIC SERVICES

IF3.2

2023-01-017

PRE